INS Holdings Berhad – a major player in the country’s biotechnology industry – is planning to list at least three of its 21 subsidiaries on the Malaysian Exchange of Securities Dealing and Automated Quotation (Mesdaq).
“It makes sense for us to list them on Mesdaq because we need to attract the kind of investors that appreciate the innovation of our business,” said company founder and CEO Datuk David Yeat Saw Chuong in an interview.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!